Xenon Pharmaceuticals Inc (XENE)

Operating Expenses

$123.16M

Quarterly · Period ending: · USD

XENE logo

XENE Operating Expenses

Latest reported$123.16M
XENE Quarterly Operating Expenses ($2.42M → $123.16M)
High-resolution chart · PNG

XENE operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
123,155,000
112,328,000
109,156,000
19,282,000
93,597,000
80,238,000
77,477,000
73,676,000
69,104,000
58,442,000
53,695,000
55,684,000
55,624,000
49,051,000
43,331,000
8,829,000
8,705,000
6,775,000
6,688,000
4,831,000
6,339,000
4,109,000
3,106,000
16,253,000
14,030,000
15,111,000
14,927,000
12,451,000
10,512,000
11,758,000
8,434,000
8,178,000
7,586,000
7,818,000
8,067,000
8,908,000
7,908,000
8,003,000
5,838,000
7,744,000
6,779,000
6,259,000
5,830,000
5,114,000
3,847,000
5,216,000
4,843,000
4,532,000
3,920,000
3,969,000
3,564,000
4,269,000
2,475,499
2,475,499
2,422,500
2,422,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.